Search Results - "Inamoto, Y"

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation by Tanaka, Y, Kurosawa, S, Tajima, K, Tanaka, T, Ito, R, Inoue, Y, Okinaka, K, Inamoto, Y, Fuji, S, Kim, S-W, Tanosaki, R, Yamashita, T, Fukuda, T

“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has curative potential against hematological malignancies. However, there are concerns about the…”
Get full text

Anatomy of the larynx and pharynx: effects of age, gender and height revealed by multidetector computed tomography by Inamoto, Y., Saitoh, E., Okada, S., Kagaya, H., Shibata, S., Baba, M., Onogi, K., Hashimoto, S., Katada, K., Wattanapan, P., Palmer, J. B.

“…Summary Although oropharyngeal and laryngeal structures are essential for swallowing, the three‐dimensional (3D) anatomy is not well understood, due in part to…”
Get full text

Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil by Terakura, S, Wake, A, Inamoto, Y, Murata, M, Sakai, R, Yamaguchi, T, Takahashi, S, Uchida, N, Onishi, Y, Ohashi, K, Ozawa, Y, Kanamori, H, Yamaguchi, H, Fukuda, T, Ichinohe, T, Takanashi, M, Atsuta, Y, Teshima, T

“…In order to examine GvHD prophylaxis in umbilical cord blood transplantation (UCBT) in more detail, we compared transplant outcomes after UCBT for acute…”
Get full text

The effect of bolus volume on laryngeal closure and UES opening in swallowing: Kinematic analysis using 320‐row area detector CT study by Shibata, S., Inamoto, Y., Saitoh, E., Kagaya, H., Aoyagi, Y., Ota, K., Akahori, R., Fujii, N., Palmer, J. B., González-Fernández, M.

“…Summary This study investigated the effects of three different volumes of honey‐thick liquid on the temporal characteristics of swallowing. Twenty‐six healthy…”
Get full text

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation by Tanaka, Y, Kurosawa, S, Tajima, K, Tanaka, T, Ito, R, Inoue, Y, Okinaka, K, Inamoto, Y, Fuji, S, Kim, S-W, Tanosaki, R, Yamashita, T, Fukuda, T

Get full text

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT by DeFilipp, Z, Duarte, R F, Snowden, J A, Majhail, N S, Greenfield, D M, Miranda, J L, Arat, M, Baker, K S, Burns, L J, Duncan, C N, Gilleece, M, Hale, G A, Hamadani, M, Hamilton, B K, Hogan, W J, Hsu, J W, Inamoto, Y, Kamble, R T, Lupo-Stanghellini, M T, Malone, A K, McCarthy, P, Mohty, M, Norkin, M, Paplham, P, Ramanathan, M, Richart, J M, Salooja, N, Schouten, H C, Schoemans, H, Seber, A, Steinberg, A, Wirk, B M, Wood, W A, Battiwalla, M, Flowers, M E D, Savani, B N, Shaw, B E

“…Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause…”
Get full text

GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia by Terakura, S, Kuwatsuka, Y, Yamasaki, S, Wake, A, Kanda, J, Inamoto, Y, Mizuta, S, Yamaguchi, T, Uchida, N, Kouzai, Y, Aotsuka, N, Ogawa, H, Kanamori, H, Nishiwaki, K, Miyakoshi, S, Onizuka, M, Amano, I, Fukuda, T, Ichinohe, T, Atsuta, Y, Murata, M, Teshima, T

“…To investigate better GVHD prophylaxis in reduced intensity conditioning umbilical cord blood transplantation (RIC-UCBT), we compared transplant outcomes after…”
Get full text

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity by Aki, S Z, Inamoto, Y, Carpenter, P A, Storer, B E, Sandmaier, B M, Lee, S J, Martin, P J, Flowers, M E D

“…The 2005 NIH chronic GVHD (cGVHD) organ severity is based on the assessment of current status regardless of whether abnormalities are due to GVHD. The score…”
Get full text

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups by Inamoto, Yoshihiro, Kimura, Fumihiko, Kanda, Junya, Sugita, Junichi, Ikegame, Kazuhiro, Nakasone, Hideki, Nannya, Yasuhito, Uchida, Naoyuki, Fukuda, Takahiro, Yoshioka, Kosuke, Ozawa, Yukiyasu, Kawano, Ichiro, Atsuta, Yoshiko, Kato, Koji, Ichinohe, Tatsuo, Inoue, Masami, Teshima, Takanori

“…Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III-IV acute graft-versus-host disease, systemically treated…”
Get full text

Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation by Liu, X., Yue, Z., Yu, J., Daguindau, E., Kushekhar, K., Zhang, Q., Ogata, Y., Gafken, P. R., Inamoto, Y., Gracon, A., Wilkes, D. S., Hansen, J. A., Lee, S. J., Chen, J. Y., Paczesny, S.

“…Improved diagnostic methods are needed for bronchiolitis obliterans syndrome (BOS), a serious complication after allogeneic hematopoietic cell transplantation…”
Get full text

Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection by Ohmoto, A, Fuji, S, Miyagi-Maeshima, A, Kim, S-W, Tajima, K, Tanaka, T, Okinaka, K, Kurosawa, S, Inamoto, Y, Taniguchi, H, Fukuda, T

Get full text

Friction and wear of several kinds of cast irons under severe sliding conditions by Hirasata, K., Hayashi, K., Inamoto, Y.

“…To clarify the dry friction and wear characteristics of several kinds of cast irons under the conditions of high sliding speed and high contact pressure was…”
Get full text

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium by Treister, N, Chai, X, Kurland, B, Pavletic, S, Weisdorf, D, Pidala, J, Palmer, J, Martin, P, Inamoto, Y, Arora, M, Flowers, M, Jacobsohn, D, Jagasia, M, Arai, S, Lee, S J, Cutler, C

“…Oral chronic GVHD (cGVHD) is a serious complication of alloSCT. Scales and instruments to measure oral cGVHD activity and severity have not been prospectively…”
Get full text

Comorbidity burden in patients with chronic GVHD by Wood, W A, Chai, X, Weisdorf, D, Martin, P J, Cutler, C, Inamoto, Y, Wolff, D, Pavletic, S Z, Pidala, J, Palmer, J M, Arora, M, Arai, S, Jagasia, M, Storer, B, Lee, S J, Mitchell, S

“…Chronic GVHD (cGVHD) is associated with mortality, disability and impaired quality of life. Understanding the role of comorbidity in patients with cGVHD is…”
Get full text

Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation by Kawajiri, A, Fuji, S, Tanaka, Y, Kono, C, Hirakawa, T, Tanaka, T, Ito, R, Inoue, Y, Okinaka, K, Kurosawa, S, Inamoto, Y, Kim, S-W, Yamashita, T, Fukuda, T

“…In order to clarify the association between hyperglycemia during the early period after allogeneic stem cell transplantation (allo-SCT) and adverse outcomes,…”
Get full text

Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy by Inamoto, Y, Ito, M, Suzuki, R, Nishida, T, Iida, H, Kohno, A, Sawa, M, Murata, M, Nishiwaki, S, Oba, T, Yanada, M, Naoe, T, Ichihashi, R, Fujino, M, Yamaguchi, T, Morishita, Y, Hirabayashi, N, Kodera, Y, Miyamura, K

“…Intestinal transplant-associated microangiopathy (i-TAM) is an important complication after allogeneic hematopoietic SCT. From 1997 to 2006, 87 of 886 patients…”
Get full text

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome by Goyal, S D, Zhang, M-J, Wang, H-L, Akpek, G, Copelan, E A, Freytes, C, Gale, R P, Hamadani, M, Inamoto, Y, Kamble, R T, Lazarus, H M, Marks, D I, Nishihori, T, Olsson, R F, Reshef, R, Ritchie, D S, Saber, W, Savani, B N, Seber, A, Shea, T C, Tallman, M S, Wirk, B, Bunjes, D W, Devine, S M, de Lima, M, Weisdorf, D J, Uy, G L

“…The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the…”
Get full text

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD by Inamoto, Y, Jagasia, M, Wood, W A, Pidala, J, Palmer, J, Khera, N, Weisdorf, D, Carpenter, P A, Flowers, M E D, Jacobsohn, D, Martin, P J, Lee, S J, Pavletic, S Z

“…The 2005 National Institutes of Health (NIH) consensus criteria for chronic GVHD have set standards for reporting. Many questions, however, have arisen…”
Get full text

Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy by Kawashima, N, Inamoto, Y, Sato, T, Nakashima, M, Kagaya, Y, Watakabe, K, Seto, A, Fukushima, N, Kurahashi, S, Ozawa, Y, Miyamura, K

Get full text

POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN PATIENTS WITH LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION by Fujimoto, A., Hiramoto, N., Yamasaki, S., Inamoto, Y., Ogata, M., Fukuda, T., Uchida, N., Ikegame, K., Matsuoka, K., Shiratori, S., Kondo, T., Miyamoto, T., Ichinohe, T., Kanda, Y., Atsuta, Y., Suzuki, R.

Get full text